InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: JDUR post# 262582

Sunday, 04/05/2020 6:05:22 PM

Sunday, April 05, 2020 6:05:22 PM

Post# of 424050
J-

-Where are the generics at in determining bio-equivalence to Vascepa with the FDA?

ANDAs were submitted in 2016, waiting for approval. Could come tomorrow …

-Can a settlement with generics be reached per settlement terms with Teva?

No way … wishful thinking

-Will AMRN give us some more info or throw us a bone with unaudited Q1 results?

Not likely … and no reason of it

-If the generic launches, will Europe honor Teva's exclusivity rights, thus voiding the 10 year exclusivity?

More =/ most likely TEVA settlement is about the US … nothing to do with Europe.

Best,
G


"There are some things money can't buy. … For these, there is AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News